Laurent Humeau

Laurent Humeau

Company: Inovio

Job title: Chief Scientific Officer


Leveraging Optimized DNA Plasmid Design and Delivery to Treat Glioblastoma Multiforme and Prostate Cancer 2:15 pm

• Presentation of clinical trial data to show a DNA based cancer vaccine in combination with FLT3 ligand and PD-1 targeting metastatic castration resistant prostate cancer • Updates on clinical status of a GBM vaccine in combination with cemiplimab (PD-1 inhibitor)Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.